--- title: "Nuvve delays Q1 2026 earnings release and conference call" type: "News" locale: "en" url: "https://longbridge.com/en/news/286550543.md" description: "Nuvve has postponed its earnings release and conference call for Q1 2026, originally scheduled for May 15, 2026. A new date and time will be announced later. The announcement was made in a press release filed as Exhibit 99.1 in Form 8-K under Regulation FD disclosure, which includes forward-looking statements." datetime: "2026-05-15T10:43:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286550543.md) - [en](https://longbridge.com/en/news/286550543.md) - [zh-HK](https://longbridge.com/zh-HK/news/286550543.md) --- # Nuvve delays Q1 2026 earnings release and conference call **Nuvve announced it is postponing its earnings press release and conference call for the quarter ended March 31, 2026.** **Key Highlights:** - Postponed previously scheduled earnings release and conference call for quarter ended March 31, 2026. - Conference call had been set for May 15, 2026 at 5:00 PM ET (2:00 PM PT); a new date and time will be announced. - Company furnished press release as Exhibit 99.1 in Form 8-K under Regulation FD disclosure. - Press release and Form 8-K include forward-looking statements and related cautionary language. Original SEC Filing: Nuvve Holding Corp. \[ NVVE \] - 8-K - May. 15, 2026 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [NVVE.US](https://longbridge.com/en/quote/NVVE.US.md) - [NVVEW.US](https://longbridge.com/en/quote/NVVEW.US.md) ## Related News & Research - [PowerFleet Q4 2026 Earnings Preview](https://longbridge.com/en/news/289616465.md) - [Goldman Sachs projects S&P 500 to reach 8,000 by 2026](https://longbridge.com/en/news/289661631.md) - [Prediction: This artificial intelligence (AI) stock will be worth 2 times as much by the end of 2026](https://longbridge.com/en/news/289377224.md) - [CarParts.com regains Nasdaq minimum $1.00 bid price compliance](https://longbridge.com/en/news/289233473.md) - [Summit Therapeutics withdraws proposed underwritten offering citing market conditions](https://longbridge.com/en/news/289460448.md)